Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,092 | 1,341 | 1,816 | 2,291 | 805 |
| TOTAL | $1,221 | $1,438 | $1,884 | $2,302 | $881 |
| Non-Current Assets | |||||
| Intangibles | 0 | 39 | 78 | 118 | 157 |
| TOTAL | $N/A | $39 | $78 | $118 | $157 |
| Total Assets | $1,221 | $1,477 | $1,962 | $2,420 | $1,038 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 630 | 245 | 415 | 244 | 203 |
| TOTAL | $732 | $246 | $417 | $247 | $206 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,584 | 2,475 | 2,415 | 2,355 | 2,296 |
| TOTAL | $2,584 | $2,475 | $2,415 | $2,355 | $2,296 |
| Total Liabilities | $3,316 | $2,721 | $2,832 | $2,602 | $2,502 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54 | 54 | 54 | 54 | 54 |
| Common Shares | 27 | 27 | 27 | 27 | 27 |
| Retained earnings | -192,609 | -191,754 | -191,376 | -190,683 | -191,961 |
| TOTAL | $-2,095 | $-1,244 | $-870 | $-182 | $-1,464 |
| Total Liabilities And Equity | $1,221 | $1,477 | $1,962 | $2,420 | $1,038 |